According to the World Health Organization (WHO), more than 300 million people worldwide suffer from depression, which is 4.4% of the world’s population. Also, depression is more common in women than men, and it affects 5.1% of women compared to 3.6% of men. There’s no denying that chronic or major depression is a debilitating condition impacting millions globally. For decades, selective serotonin reuptake inhibitors (SSRIs) have been the go-to treatment for people. However, recent research suggests that there are alternate treatments for this that may not only be more effective but could also offer long-term relief by addressing the root cause of depression (Source: https://www.who.int/bangladesh/news/detail/28-02-2017-number-of-people-with-depression-increases).

Yes, we are talking about Psilocybin. Before you start searching for professional therapists in Cedar Rapids, Iowa, or St Thomas, USVI, here’s everything you need to know about the debate between conventional SSRIs and psilocybin and why the shift represents a critical evolution in mental health care.